Cases & Deals

i2Dx issues Convertible Promissory Notes to Biomark Capital

Clients i2Dx, Inc.

Jones Day advised i2Dx, Inc., a developer of a multimodal cloud-based diagnostic platform for the assessment of neurologicals, in connection with its issuance of Convertible Promissory Notes in a private placement to Biomark Capital.